Multiple myeloma symptoms often include persistent bone pain, extreme fatigue, frequent infections, and kidney dysfunction. These signs arise when cancerous plasma cells crowd the bone marrow and disrupt normal blood and bone function. Early detection through blood and urine tests remains critical for managing this hematologic malignancy effectively.
Medical professionals often categorize the primary indicators of multiple myeloma using the “CRAB” acronym, which stands for calcium elevation, renal insufficiency, anemia, and bone disease. According to the Mayo Clinic, these symptoms can appear suddenly or develop gradually, often mimicking other more common conditions like arthritis or general aging.
What are the most common signs of multiple myeloma?
The most prevalent symptom reported by patients is bone pain. This discomfort typically occurs in the spine, ribs, or skull. Unlike standard aches, this pain often persists even during rest and can feel deep or throbbing. This occurs because the malignant plasma cells interfere with the body’s ability to regulate bone mineral density.
Fatigue is another frequent indicator. Patients often describe a sense of exhaustion that does not improve with sleep. This weakness is largely driven by anemia, a condition where the body lacks enough healthy red blood cells to carry oxygen to vital tissues. As cancerous cells multiply in the bone marrow, they physically crowd out the production of healthy red blood cells.
Infections represent a third significant symptom. While plasma cells are a type of white blood cell intended to fight infection, the cells produced in multiple myeloma are abnormal and dysfunctional. They cannot effectively defend the body against bacteria or viruses. Consequently, individuals may experience repeated bouts of pneumonia, urinary tract infections, or skin infections. The American Cancer Society notes that these recurrent infections are a hallmark of the immune system’s failure in myeloma patients.
Why does multiple myeloma cause bone pain and fractures?
Multiple myeloma directly attacks the skeletal system. The primary mechanism involves a disruption in the balance between bone-building cells (osteoblasts) and bone-resorbing cells (osteoclasts). The cancerous plasma cells trigger an overproduction of osteoclasts, which accelerate the breakdown of bone tissue.
This continuous destruction leads to several clinical issues:
- Lytic lesions: These are “holes” or weakened spots in the bone that appear on X-rays or MRI scans.
- Pathologic fractures: These are breaks that occur during normal activities, such as walking or even coughing, because the bone structure has become too brittle to support weight.
- Spinal compression: If the vertebrae in the spine are weakened, they can collapse, potentially pressing against the spinal cord and causing neurological issues.
The National Cancer Institute states that bone involvement is one of the most debilitating aspects of the disease, often requiring specialized treatments like bisphosphonates or radiation to stabilize bone density.
How does the disease affect kidney function and calcium levels?
The relationship between multiple myeloma and kidney health is complex. Cancerous plasma cells produce an abnormal protein known as M-protein (or monoclonal protein). When these proteins, specifically “light chains,” circulate in high volumes, they can clog the filtering units of the kidneys, known as glomeruli.
This accumulation leads to renal insufficiency or kidney failure. Doctors monitor kidney function through creatinine levels in the blood and protein levels in the urine. If the kidneys cannot filter waste effectively, toxins build up in the bloodstream, which can further complicate the patient’s overall health.
High calcium levels, or hypercalcemia, often accompany kidney issues. As bone tissue breaks down due to the cancer, the calcium stored in the bones is released into the bloodstream. Hypercalcemia can cause various systemic problems, including:
- Confusion and disorientation.
- Nausea and vomiting.
- Constipation.
- Increased thirst and frequent urination.
Addressing hypercalcemia is a clinical priority, as extremely high calcium levels can lead to cardiac issues or coma if left untreated.
What is the difference between smoldering and active myeloma?
Not everyone with abnormal plasma cells has active cancer. Medical researchers distinguish between “smoldering multiple myeloma” and “active multiple myeloma.” Smoldering myeloma is an asymptomatic stage where plasma cells are elevated, but the patient does not yet show the “CRAB” symptoms described above.
Active multiple myeloma is characterized by the presence of end-organ damage, such as the bone, kidney, or blood issues mentioned previously. While smoldering myeloma requires close monitoring through regular blood work and imaging, active myeloma necessitates immediate therapeutic intervention to prevent further damage to the skeletal and renal systems.
When should you consult a doctor about these symptoms?
Because multiple myeloma symptoms overlap with many other conditions, they are often dismissed initially. However, medical experts advise seeking a consultation if you experience any of the following:
- Unexplained, persistent bone or back pain.
- Extreme fatigue that interferes with daily activities.
- Frequent, unexplained infections.
- Sudden changes in urination frequency or color.
- Unexplained weight loss or loss of appetite.
Diagnosis typically begins with routine blood tests, such as a complete blood count (CBC) and serum protein electrophoresis (SPEP), to detect abnormal proteins. If these tests indicate an issue, doctors may proceed to a bone marrow biopsy to confirm the presence of malignant plasma cells and determine the specific subtype of the disease.
Frequently Asked Questions
Is multiple myeloma contagious?
No. Multiple myeloma is a cancer of the blood and bone marrow; it cannot be spread from person to person through contact or fluids.
Who is most at risk for developing multiple myeloma?
Risk increases with age, as most diagnoses occur in adults over the age of 65. While it can affect anyone, certain demographic groups show slightly higher incidence rates, though the exact causes remain under study.
Can multiple myeloma be cured?
Currently, most medical experts view multiple myeloma as a manageable chronic condition rather than a curable one. However, significant advancements in targeted therapies, immunotherapies, and stem cell transplants allow many patients to achieve long-term remission and maintain a high quality of life.
The next major step for clinical research in this field involves the ongoing monitoring of new immunotherapy drugs in phase III clinical trials. Check with your healthcare provider or official oncology registries for updates on upcoming clinical research participation.
If you found this information helpful, please share this article with your network or leave a comment below with your questions.